Wall Street analysts expect Encompass Health Corp (NYSE:EHC) to report sales of $1.06 billion for the current quarter, Zacks reports. Six analysts have provided estimates for Encompass Health’s earnings, with the lowest sales estimate coming in at $1.05 billion and the highest estimate coming in at $1.07 billion. Encompass Health reported sales of $995.60 million in the same quarter last year, which indicates a positive year over year growth rate of 6.5%. The company is expected to report its next quarterly earnings report on Thursday, October 25th.

On average, analysts expect that Encompass Health will report full-year sales of $4.26 billion for the current year, with estimates ranging from $4.24 billion to $4.28 billion. For the next financial year, analysts expect that the business will post sales of $4.51 billion per share, with estimates ranging from $4.47 billion to $4.54 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of analysts that that provide coverage for Encompass Health.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Wednesday, July 25th. The company reported $0.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.83 by $0.16. Encompass Health had a net margin of 7.32% and a return on equity of 22.57%. The firm had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.03 billion.

A number of equities research analysts have recently issued reports on the stock. Mizuho reissued a “buy” rating and set a $82.00 price objective on shares of Encompass Health in a research report on Thursday, July 26th. Piper Jaffray Companies raised shares of Encompass Health from a “neutral” rating to an “overweight” rating in a research report on Thursday, July 26th. Finally, Credit Suisse Group boosted their price objective on shares of Encompass Health from $66.00 to $80.00 and gave the company an “outperform” rating in a research report on Thursday, July 26th. One equities research analyst has rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $73.00.

Shares of EHC stock traded up $0.66 during mid-day trading on Friday, reaching $79.93. 22,011 shares of the company’s stock traded hands, compared to its average volume of 534,111. Encompass Health has a 12 month low of $43.32 and a 12 month high of $82.46. The company has a debt-to-equity ratio of 1.73, a current ratio of 1.17 and a quick ratio of 1.17. The company has a market cap of $7.86 billion, a price-to-earnings ratio of 28.91, a PEG ratio of 1.88 and a beta of 0.31.

The company also recently announced a quarterly dividend, which will be paid on Monday, October 15th. Investors of record on Monday, October 1st will be issued a $0.27 dividend. The ex-dividend date of this dividend is Friday, September 28th. This represents a $1.08 annualized dividend and a yield of 1.35%. This is an increase from Encompass Health’s previous quarterly dividend of $0.25. Encompass Health’s dividend payout ratio is currently 36.23%.

Encompass Health Company Profile

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Recommended Story: Fundamental Analysis and Individual Investors

Get a free copy of the Zacks research report on Encompass Health (EHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.